Research ArticleArticle
Impaired Health Status and the Effect of Pain and Fatigue on Functioning in Clinical Trial Patients with Systemic Lupus Erythematosus
Michelle Petri, Ariane K. Kawata, Ancilla W. Fernandes, Kavita Gajria, Warren Greth, Asha Hareendran and Dominique Ethgen
The Journal of Rheumatology October 2013, jrheum.130046; DOI: https://doi.org/10.3899/jrheum.130046
Michelle Petri
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
Ariane K. Kawata
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
Ancilla W. Fernandes
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
Kavita Gajria
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
Warren Greth
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
Asha Hareendran
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
Dominique Ethgen
From the Johns Hopkins University School of Medicine, Baltimore, Maryland; United BioSource Corporation, Bethesda, Maryland; and MedImmune LLC, Gaithersburg, Maryland, USA. Sponsored by MedImmune LLC, including support for research and manuscript preparation. MP is affiliated with Johns Hopkins University School of Medicine and has consultancy agreements with MedImmune, UCB, Pfizer, Human Genome Sciences, GlaxoSmithKline, TEVA, and Anthera Pharmaceuticals. AKK and AH are employees of United BioSource Corporation. AF and WG are employees of MedImmune LLC. DE was an employee of MedImmune LLC at the time this study was conducted. KG was an employee of MedImmune LLC at the time of study conduct and writing of the manuscript. M. Petri, MD, MPH, Johns Hopkins University School of Medicine; A.K. Kawata, PhD, United BioSource Corporation; A.W. Fernandes, PhD; K. Gajria, BSPharm, MS; W. Greth, MD, MSc, MedImmune LLC; A. Hareendran, PhD, United BioSource Corporation; D. Ethgen*, MD, MedImmune LLC. *Dr. Ethgen died May 13, 2012. Address correspondence to A.K. Kawata, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. E-mail: ariane.kawata@unitedbiosource.com Accepted for publication July 16, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Impaired Health Status and the Effect of Pain and Fatigue on Functioning in Clinical Trial Patients with Systemic Lupus Erythematosus
Michelle Petri, Ariane K. Kawata, Ancilla W. Fernandes, Kavita Gajria, Warren Greth, Asha Hareendran, Dominique Ethgen
The Journal of Rheumatology Oct 2013, jrheum.130046; DOI: 10.3899/jrheum.130046
Impaired Health Status and the Effect of Pain and Fatigue on Functioning in Clinical Trial Patients with Systemic Lupus Erythematosus
Michelle Petri, Ariane K. Kawata, Ancilla W. Fernandes, Kavita Gajria, Warren Greth, Asha Hareendran, Dominique Ethgen
The Journal of Rheumatology Oct 2013, jrheum.130046; DOI: 10.3899/jrheum.130046